Published in Lung Cancer on August 01, 1997
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol (2009) 4.95
How well do doctors know their patients? Factors affecting physician understanding of patients' health beliefs. J Gen Intern Med (2010) 1.83
Patient-oncologist communication in advanced cancer: predictors of patient perception of prognosis. Support Care Cancer (2008) 1.27
Patients rate physician communication about lung cancer. Cancer (2011) 1.16
Predictors of family conflict at the end of life: the experience of spouses and adult children of persons with lung cancer. Gerontologist (2009) 0.97
Identifying and predicting subgroups of information needs among cancer patients: an initial study using latent class analysis. Support Care Cancer (2010) 0.95
Outcomes of Prognostic Disclosure: Associations With Prognostic Understanding, Distress, and Relationship With Physician Among Patients With Advanced Cancer. J Clin Oncol (2015) 0.93
The development and preliminary testing of a multimedia patient-provider survivorship communication module for breast cancer survivors. Patient Educ Couns (2012) 0.89
In the shadow of bad news - views of patients with acute leukaemia, myeloma or lung cancer about information, from diagnosis to cure or death. BMC Palliat Care (2007) 0.88
Deciding what information is necessary: do patients with advanced cancer want to know all the details? Cancer Manag Res (2011) 0.88
The trajectory to diagnosis with pulmonary arterial hypertension: a qualitative study. BMJ Open (2012) 0.87
A treatment trade-off based decision aid for patients with locally advanced non-small cell lung cancer. Health Expect (2000) 0.85
Missed opportunities for advance care planning communication during outpatient clinic visits. J Gen Intern Med (2011) 0.83
Patient-centred care: making cancer treatment centres accountable. Support Care Cancer (2014) 0.82
A Web-based communication aid for patients with cancer: the CONNECT Study. Cancer (2013) 0.81
Perceptions of medical interactions between healthcare providers and American Indian older adults. Soc Sci Med (2008) 0.79
Information from physicians and retention of information by patients - obstacles to the awareness of patients of progressing disease when life is near the end. BMC Palliat Care (2008) 0.79
Association of patient-provider communication domains with lung cancer treatment. J Thorac Oncol (2014) 0.77
Informed decision making in advance care planning: concordance of patient self-reported diagnosis with physician diagnosis. Support Care Cancer (2012) 0.77
A voice that wraps around the body--communication problems in the advanced stages of non-small cell lung cancer. Yale J Biol Med (2002) 0.75
Patient, companion, and oncologist agreement regarding information discussed during triadic oncology clinical interactions. Psychooncology (2012) 0.75
Making an informed decision of Korean cancer patients: the discrepancy between a patient's recall of information and the information needed for acquisition of radiotherapy informed consent. Support Care Cancer (2017) 0.75
High-performance lithium-ion anodes using a hierarchical bottom-up approach. Nat Mater (2010) 3.25
Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol (1998) 3.24
Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol (2002) 2.99
What questions do patients with curable prostate cancer want answered? Med Decis Making (2000) 2.93
Isolation of a cDNA for HSF2: evidence for two heat shock factor genes in humans. Proc Natl Acad Sci U S A (1991) 2.89
Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys (1994) 2.77
Cancer patients' perceptions of their disease and its treatment. Br J Cancer (1988) 2.66
The TEAM (Total Exposure Assessment Methodology) Study: personal exposures to toxic substances in air, drinking water, and breath of 400 residents of New Jersey, North Carolina, and North Dakota. Environ Res (1987) 2.53
Do minutes count? Consultation lengths in general practice. J Health Serv Res Policy (1998) 2.23
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1993) 2.22
Perception of quantitative information for treatment decisions. Med Decis Making (2000) 2.04
Patterns of failure following loco-regional radiotherapy in the treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys (1994) 2.01
Does a centralized radiotherapy system provide adequate access to care? J Clin Oncol (1997) 1.90
Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer (2001) 1.90
Controversies in the management of non-small cell lung cancer: the results of an expert surrogate study. Radiother Oncol (1990) 1.88
Particulate matter and heart rate variability among elderly retirees: the Baltimore 1998 PM study. J Expo Anal Environ Epidemiol (2001) 1.85
Associations between community income and cancer survival in Ontario, Canada, and the United States. J Clin Oncol (1999) 1.81
Restoring the balance between research and medical education. Can Med Assoc J (1984) 1.79
A population-based study of malignant spinal cord compression in Ontario. Clin Oncol (R Coll Radiol) (2003) 1.60
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia (2010) 1.53
The use of expert surrogates to evaluate clinical trials in non-small cell lung cancer. Br J Cancer (1986) 1.53
Controversies in prostate cancer radiotherapy: consensus development. Can J Urol (2001) 1.51
Psychiatric illness and psychosocial concerns of patients with newly diagnosed lung cancer. CMAJ (1995) 1.50
Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: a population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys (1999) 1.43
Intensity-modulated radiotherapy in the treatment of breast cancer. Clin Oncol (R Coll Radiol) (2012) 1.42
Cancer patients' attitudes toward treatment options for advanced non-small cell lung cancer: implications for patient education and decision support. Patient Educ Couns (2001) 1.42
Decision analysis in locally advanced non-small-cell lung cancer: is it useful? J Clin Oncol (1997) 1.40
Changes in the use of radiotherapy in Ontario 1984-1995. Int J Radiat Oncol Biol Phys (1999) 1.36
Ethical problems in clinical research: the need for empirical studies of the clinical trials process. J Chronic Dis (1986) 1.36
A stem cell model of human tumor growth: implications for tumor cell clonogenic assays. J Natl Cancer Inst (1983) 1.35
A comparison of published head and neck stage groupings in carcinomas of the oral cavity. Head Neck (2001) 1.34
Ribosomes in thiostrepton-resistant mutants of Bacillus megaterium lacking a single 50 S subunit protein. J Mol Biol (1979) 1.29
Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach. Int J Radiat Oncol Biol Phys (2001) 1.27
The influence of fish cage aquaculture on pelagic carbon flow and water chemistry in tidally dominated mangrove estuaries of peninsular Malaysia. Mar Environ Res (2003) 1.26
Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol (2001) 1.25
Correlations among human blood levels of specific PCB congeners and implications for epidemiologic studies. Am J Ind Med (1997) 1.22
An assessment of US and Canadian smoking reduction objectives for the year 2000. Am J Public Health (1998) 1.22
Trading treatment toxicity for survival in locally advanced non-small cell lung cancer. J Clin Oncol (1997) 1.22
Time spent in hospital in the last six months of life in patients who died of cancer in Ontario. J Clin Oncol (2002) 1.21
Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group. J Clin Oncol (2005) 1.21
The 1998 Baltimore Particulate Matter Epidemiology-Exposure Study: part 1. Comparison of ambient, residential outdoor, indoor and apartment particulate matter monitoring. J Expo Anal Environ Epidemiol (2001) 1.21
Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol (1992) 1.20
Cancer Care Ontario Colonoscopy Standards: standards and evidentiary base. Can J Gastroenterol (2007) 1.20
Waiting times for cancer surgery in Ontario: 1984-2000. Clin Oncol (R Coll Radiol) (2006) 1.20
The role of palliative thoracic radiotherapy in non-small cell lung cancer. Can J Oncol (1996) 1.20
University of Alberta norms of relative meaning frequency for 566 homographs. Mem Cognit (1994) 1.20
A shorter fractionation schedule for postlumpectomy breast cancer patients. Int J Radiat Oncol Biol Phys (2000) 1.19
The 1998 Baltimore Particulate Matter Epidemiology-Exposure Study: part 2. Personal exposure assessment associated with an elderly study population. J Expo Anal Environ Epidemiol (2001) 1.18
The impact of nursing grade on the quality and outcome of nursing care. Health Econ (1995) 1.16
Percutaneous lumbar diskectomy using a new aspiration probe. AJR Am J Roentgenol (1985) 1.15
Non-small cell lung cancer: how oncologists want to be treated. Int J Radiat Oncol Biol Phys (1987) 1.12
Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma. Cancer Res (1992) 1.12
Supportive care management of brain metastases: what is known and what we need to know. Conference proceedings of the National Cancer Institute of Canada (NCIC) Workshop on Symptom Control in Radiation Oncology. Clin Oncol (R Coll Radiol) (2003) 1.09
Associations between socioeconomic status and cancer survival: choice of SES indicator may affect results. Ann Epidemiol (2006) 1.07
Explaining socioeconomic status effects in laryngeal cancer. Clin Oncol (R Coll Radiol) (2006) 1.05
Myeloproliferative disorders: a paradox of in-vivo and in-vitro platelet function. J Clin Pathol (1977) 1.05
Radiotherapy for breast cancer in Ontario: rate variation associated with region, age and income. Clin Invest Med (1998) 1.05
Increased level of translatable collagenase messenger ribonucleic acid in rabbit synovial fibroblasts treated with phorbol myristate acetate or crystals of monosodium urate monohydrate. Biochemistry (1982) 1.04
Risk of thyroid carcinoma in a female population after radiotherapy for breast carcinoma. Cancer (2001) 1.02
Factors associated with referral to medical oncology and subsequent use of adjuvant chemotherapy for non-small-cell lung cancer: a population-based study. Curr Oncol (2013) 1.02
Site of action of clomiphene and its use as a test of pituitary function. J Obstet Gynaecol Br Commonw (1971) 1.01
Dynamic illusion effects in a reaching task: evidence for separate visual representations in the planning and control of reaching. J Exp Psychol Hum Percept Perform (2001) 1.01
Late onset in dysferlinopathy widens the clinical spectrum. Neuromuscul Disord (2008) 1.01
What prostate cancer patients should know: variation in professionals' opinions. Radiother Oncol (1998) 0.99
A comparison of published head and neck stage groupings in carcinomas of the tonsillar region. Cancer (2001) 0.98
The influence of human activity patterns on personal PM exposure: a comparative analysis of filter-based and continuous particle measurements. J Air Waste Manag Assoc (2001) 0.97
The macular photostress test in diabetic retinopathy and age-related macular degeneration. Arch Ophthalmol (1990) 0.97
Involved-field radiotherapy alone for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2000) 0.97
Glottic cancer in Ontario, Canada and the SEER areas of the United States. Do different management philosophies produce different outcome profiles? J Clin Epidemiol (2001) 0.96
Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States. Cancer (2000) 0.95
Does knowledge guide practice? Another look at the management of non-small-cell lung cancer. J Clin Oncol (1995) 0.95
The consultation to develop a national strategy for cancer staging in Canada. Cancer Prev Control (1998) 0.95
A real-time audit of radiation therapy in a regional cancer center. Int J Radiat Oncol Biol Phys (1999) 0.94
Herpes simplex virus infection in rabbit eye. Arch Ophthalmol (1972) 0.94
May-Hegglin anomaly: a defect in megakaryocyte fragmentation? Br J Haematol (1974) 0.94
Association between age and the utilization of radiotherapy in Ontario. Int J Radiat Oncol Biol Phys (2000) 0.92
Osteochondritis dissecans of the knee; long-term clinical outcome following arthroscopic debridement. Knee (2007) 0.92
Changes associated with platelet aging. Thromb Diath Haemorrh (1972) 0.92
Enzyme-linked immunosorbent assay for the diagnosis of bovine leukosis: comparison with the agar gel immunodiffusion test approved by the Canadian Food Inspection Agency. Can J Vet Res (2000) 0.92
Monitoring outcomes in routine practice: defining appropriate measurement criteria. J Eval Clin Pract (1996) 0.92
Induction of human neonatal pulmonary fibroblast cytokines by hyperoxia and Ureaplasma urealyticum. Clin Infect Dis (1993) 0.91
Using a treatment-tradeoff method to elicit preferences for the treatment of locally advanced non-small-cell lung cancer. Med Decis Making (1998) 0.90
Teams and seams: skill mix in primary care. J Adv Nurs (1998) 0.90
Phase I study of a decision aid for patients with locally advanced non-small-cell lung cancer. J Clin Oncol (2001) 0.90
Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype. Ann Neurol (2001) 0.89
Effect of complexed synthetic RNA analogues on herpes simplex virus infection in rabbit cornea. Am J Ophthalmol (1970) 0.89
Motor adaptation to an optical illusion. Exp Brain Res (2001) 0.89
Cellular heterogeneity in human ovarian carcinoma studied by density gradient fractionation. Stem Cells (1982) 0.89
Comparing the predictive value of neural network models to logistic regression models on the risk of death for small-cell lung cancer patients. Eur J Cancer Care (Engl) (2006) 0.88
Contribution of children's activities to lead contamination of food. J Expo Anal Environ Epidemiol (2001) 0.87
Cellular heterogeneity in normal human urothelium: an analysis of optical properties and lectin binding. J Histochem Cytochem (1986) 0.87
The management and outcome of bladder carcinoma in Ontario, 1982-1994. Cancer (2000) 0.87
Density/volume analysis in the study of cellular heterogeneity in human ovarian carcinoma. Br J Cancer (1982) 0.87
Cellular heterogeneity in normal and neoplastic human urothelium. Cancer Res (1985) 0.86